Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06099158 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Danish Pragmatic Randomized Trial to Evaluate the Effect of HeartLogic-Guided Management on Heart Failure Outcomes

Study acronym: DANLOGIC-HF
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary and study completion dates: May 1, 2027 to Dec 1, 2027
    • Start date changed from estimate of Nov 1, 2023 to May 31, 2024
    • Study description shortened, about 6 words
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to assess the impact of HeartLogic-guided management on clinical outcomes among patients implanted with an eligible cardiac device.
Trial Details
NCT Number NCT06099158
Lead Sponsor Tor Biering-Sørensen
Collaborators: Boston Scientific Corporation
Conditions
(from sponsor)		 Heart Failure
Related terms Heart Diseases, Heart Failure
Enrollment 1,428 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov